Dr Reddy’s launches Remdesivir under ‘Redyx’ brand name for COVID-19 treatment in India
Hyderabad: Dr Reddys Laboratories Ltd Wednesday announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India. According to a press release from the drug maker, the launch is part of the licensing agreement with Gilead Sciences, Inc....











































